The next chapter of the right-wing war on the Affordable Care Act involves a case that targets the preventative care that ...

But just seven years ago, and despite living with HIV for nearly half his life, Duffy was remarkably healthy, working in ...

CNBC’s Angelica Peebles and Gilead chairman and CEO Daniel O’Day join 'Squawk Box' to discuss the company's new HIV ...

Discover the latest advancements in HIV prevention and how they offer hope for reducing infections, especially in the Black ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Here are some of the findings from UNAIDS' new report on HIV and human rights, and what they could mean for the fight against ...

Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells ...

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine.

Although the association between HIV and long COVID was inconclusive, the prevalence of long COVID in patients with HIV was ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Among treatment-naive people with HIV, dolutegravir/lamivudine showed viral suppression comparable with those of other ...

The government provides HIV medicines free of charge. Yet in one Indigenous territory, cases and deaths are increasing at an ...